| Announce Date | 02/06/2026 |
| EPS Normalized Actual | $3.88 (Beat by $0.8) |
| EPS GAAP Actual | $3.88 (Beat by $0.8) |
| Revenue Actual | $0.814867B |
| Revenue Surprise | Beat by $814.867M |
| Announce Date | 03/30/2026 (Pre-Market) |
| EPS Normalized Estimate | $2.22 |
| EPS GAAP Estimate | $2.22 |
| Revenue Estimate | $0.626007075B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Jun 2027 | 9.03 | 68.92 | 8.81033 | 9.24965 | 0 |
| Jun 2026 | 8.95 | 69.53 | 8.57999 | 9.31998 | 0 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ4 2025 (Dec 2025) | 3.86 | 1.81 | 0.814867B | 26.38% | 207.36M |
| FQ3 2025 (Sep 2025) | 3.44 | 1.017 | 0.733773B | 25% | 117.44M |
| FQ2 2025 (Jun 2025) | 4.41 | 4.41 | 0.759152B | 33.15% | 759.15M |
| FQ1 2025 (Mar 2025) | 2.98 | 0.98 | 0.66417B | 25.77% | 84.57M |
| FQ4 2024 (Dec 2024) | 2.26 | 0.1985 | 0.599879B | 22.49% | 14.85M |
| FQ3 2024 (Sep 2024) | 2.12 | 0.57859 | 0.550344B | 15.86% | -375.81M |
| FQ2 2024 (Jun 2024) | 1.72 | 1.72 | 0.507461B | 3.23% | 507.46M |
| FQ1 2024 (Mar 2024) | 1.26 | 1.26 | 0.492997B | 7.14% | 493M |
FQ4 Announce Date
03/30/2026 (Pre-Market)
Consensus EPS Estimates
2.22
Consensus Revenue Estimates
0.626007075B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ1 2027 (Mar 2027) | 3.051 | -- | 2.98795 | 3.11405 | 1 |
| FQ4 2026 (Dec 2026) | 2.919 | -32.24 | 2.85868 | 2.97932 | 1 |
| FQ3 2026 (Sep 2026) | 2.801 | -22.81 | 2.75955 | 2.84243 | 1 |
| FQ1 2026 (Mar 2026) | 2.22 | -34.23 | 2.0409 | 2.3991 | 0 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ1 2027 (Mar 2027) | 0.89B | -- | 0.87B | 0.9B | 1 |
| FQ4 2026 (Dec 2026) | 0.87B | 5.89 | 0.85B | 0.88B | 1 |
| FQ3 2026 (Sep 2026) | 0.8B | 7.71 | 0.79B | 0.8B | 1 |
| FQ1 2026 (Mar 2026) | 0.63B | -6.1 | 0.59B | 0.66B | 1 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
8
EPS # of Misses
0
EPS # of in-lines
0
Revenue # of Beats
7
Revenue # of Misses
1
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ4 2025 (Dec 2025) | 2.05 | 3.86 | 1.81 | 46.89% |
| FQ3 2025 (Sep 2025) | 2.423 | 3.44 | 1.017 | 29.56% |
| FQ2 2025 (Jun 2025) | 4.41 | 4.41 | 100% | |
| FQ1 2025 (Mar 2025) | 2 | 2.98 | 0.98 | 32.89% |
| FQ4 2024 (Dec 2024) | 2.0615 | 2.26 | 0.1985 | 8.78% |
| FQ3 2024 (Sep 2024) | 1.54141 | 2.12 | 0.57859 | 27.29% |
| FQ2 2024 (Jun 2024) | 1.72 | 1.72 | 100% | |
| FQ1 2024 (Mar 2024) | 1.26 | 1.26 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ4 2025 (Dec 2025) | $0.61B | $0.81B | $207.36M | 25.45% |
| FQ3 2025 (Sep 2025) | $0.62B | $0.73B | $117.44M | 16.01% |
| FQ2 2025 (Jun 2025) | $0B | $0.76B | $759.15M | 100% |
| FQ1 2025 (Mar 2025) | $0.58B | $0.66B | $84.57M | 12.73% |
| FQ4 2024 (Dec 2024) | $0.59B | $0.6B | $14.85M | 2.48% |
| FQ3 2024 (Sep 2024) | $0.93B | $0.55B | $-375.81M | -68.29% |
| FQ2 2024 (Jun 2024) | $0B | $0.51B | $507.46M | 100% |
| FQ1 2024 (Mar 2024) | $0B | $0.49B | $493M | 100% |